Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

MAIDENHEAD, England, September 23 /PRNewswire/ --

- Data Represents More than 800 Patient Years of Experience

Wyeth today announced study results from last week's 15th Paediatric Rheumatology European Congress (PRES) in London which highlight the safety record of etanercept (ENBREL(R)) as a continuous therapy in children and adolescents with juvenile idiopathic arthritis (JIA).(1)

SAN JOSE, California, September 23 /PRNewswire/ --

- In its Latest Malicious Page of the Month Report, Finjan Describes the Malicious Obfuscated Code Evolution, Including Examples of its Increased Sophistication and Effectiveness

Finjan Inc., a leader in secure web gateway products, today announced that its Malicious Code Research Center (MCRC) discovered examples of obfuscated code embedded in rich-content files, and not only in HTML-webpages on legitimate websites.

http://www.newscom.com/cgi-bin/prnh/20080618/309345

MOUNTAIN VIEW, California, September 23 /PRNewswire/ --

Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced its plan to sponsor a prospective randomized clinical trial comparing intervention using the Merci Retrieval System(TM) with best medical therapy.

A steering committee comprised of clinical experts from around the world has agreed to support and help guide the trial, named RETRIEVE (Randomized trial of Endovascular TReatment of acute Ischemic strokE Versus mEdical management). The trial, which will enroll in centers throughout the world, will randomize patients between treatment with the Merci Retriever(R) and non-interventional, best medical therapy. Enrollment is expected to begin in 2009.

MUMBAI, India, September 23 /PRNewswire/ --

- Impressive Early Performance of In.com (beta) Propels Web18, Network18's Internet Company to No.2 Position

Within a few weeks of being available in beta mode, in.com has made a spectacular start. In.com is the latest online foray from Web18, one of India's leading online networks. The site is set to redefine online usage with a unique user proposition, which builds on the strongest benefits that the internet delivers and then maps that to community choices through a smart aggregation model. Available for access since August 2008, in.com is already in the top Indian websites.

To view the Multimedia News Release, please click:

http://www.prnewswire.com/mnr/web18/35063

LJUBLJANA, Slovenia, September 23 /PRNewswire/ -- XLAB, the parent company of the remote support, work and collaboration tools SL Online, has signed a consulting contract with the Japanese technology group NEC, thus proving once again that their experts are a worthy choice in a competitive global market. XLAB and NEC are bound to a long-term partnership to develop an alternative system software for the NEC SX vector supercomputer architecture.

The companies first met in 2006, when cooperating in the 6th FP research project, XtreemOS (http://www.xtreemos.eu). Their aim was to design, develop and promote a Linux-based operating system with native support for establishing large-scale virtual organisations on future generation networks.

PHOENIX, September 23 /PRNewswire/ --

seeitgolf today announced the release of its first product, Aaron Baddeley: Putting, a groundbreaking tool for golfers to mentally improve their game and literally change their minds about how they putt.

"I have always included visualization in my mental routine. When I visualize putts in a tournament, I see the ball roll in the hole over and over again in my mind so by the time I stand over the ball, I already believe the ball will roll in," said Aaron Baddeley. "Aaron Baddeley: Putting allows players to see the game through my eyes and use the same techniques I rely on. It's simple, but it's very, very effective."